Physician profile
Iley Neely
NPI 1700810348
$1,283.54
in general payments reported to CMS, 2019-2025
17 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $147 · 2021: $336 · 2022: $131 · 2023: $101 · 2024: $112 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $195.23 | 2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $174.47 | 2019-2021 | |
| Allergan, INC. | $146.09 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $143.62 | 2019-2024 | Tecnis Iol, Whitestar Signature Pro |
| Novartis Pharmaceuticals Corporation | $126.83 | 2020-2023 | |
| Alcon Vision LLC | $108.19 | 2022-2025 | Simbrinza, Rocklatan, Clareon |
| Sun Pharmaceutical Industries INC. | $74.42 | 2019-2022 | |
| Optovue, INC. | $65.51 | 2019 | |
| Horizon Therapeutics Plc | $51.22 | 2021-2022 | |
| Shire North American Group INC | $37.30 | 2019 | |
| Dompe US, INC. | $36.91 | 2024 | Oxervate |
| Mallinckrodt Hospital Products INC. | $34.43 | 2021 | |
| Amgen INC. | $25.45 | 2024 | Tepezza |
| Kala Pharmaceuticals, INC. | $22.53 | 2021 | |
| Omeros Corporation | $14.66 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $13.62 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iley Neely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.